Stay updated on Nivolumab in AML Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in AML Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in AML Prevention Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study record’s latest update dates changed from November 13 and 11, 2026, to November 18 and 16, 2026. The website revision advanced from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-21T14:49:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The study record’s update dates changed, reflecting a newer record submission and posting.
    Difference
    0.1%
    Check dated 2026-11-14T14:29:58.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” and related updates is no longer displayed at the top of the page.
    Difference
    1%
    Check dated 2026-11-07T14:27:54.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T15:13:59.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A banner was added announcing an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study record content remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T15:36:29.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T15:26:52.000Z thumbnail image

Stay in the know with updates to Nivolumab in AML Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Prevention Clinical Trial page.